Found: 4
Select item for more details and to access through your institution.
Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0129012
- By:
- Publication type:
- Article
PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Additive clinical impact of epidermal growth factor receptor and podocalyxin-like protein expression in pancreatic and periampullary adenocarcinomas.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-67187-z
- By:
- Publication type:
- Article
TKTL1 as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma and Its Correlation with FDG-PET-CT.
- Published in:
- Oncology, 2021, v. 99, n. 3, p. 177, doi. 10.1159/000510862
- By:
- Publication type:
- Article